| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Finance > Understanding Basic Finance Terms |
|
Advice You - Understanding Basic Finance Terms
If your like many, you don’t always understand what people are talking about when it comes to loans. Without underst According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product anding the basic terminology when it comes to loans you just aren’t setting yourself up right to make an educated de ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in cision when it comes to applying for a loan. There are hundreds of terms; Below are some of the most important: lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ssets Assets can be described as anything that holds value. Assets can be all types of things from cars to here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe houses. Assets can be used in helping to build credit. For example if you are applying for a house loan, you might u d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro e your car as an asset, to show that if you default on a payment, that you have assets to fall back upon such as you ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc r car. Capital Capital can be a bit of tricky term as it can be used in several different situations to easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi do with finances. Capital can be described as the assets that are available for use towards creating further assets nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically it can also apply to the cash in reserve, savings, property, or goods. Debt Debt is amount of money or and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ something of value that is borrowed from a person referred to as a debtor. Usually a debt that is borrowed will car ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi y some type of penalty along with the payback such as an interest, or service. Debt Consolidation Debt ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a Consolidation is replacing multiple loans with a single loan that is normally secured on property. This can often re dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod duce your (the borrowers) monthly outgoing interest payments by paying only one loan which is secured on the propert cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin sometimes over a longer term. Because the loan is secured, the interest rate will generally be considerably lower. tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen Equity Equity is the difference between the value of a product (for example a house) and the amount tha t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel is owed on it. Liabilities Liabilities refers to the sum of all outstanding debts in which a company o ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust r individual owes to it’s debtors. Principal Principal is used to describe the amount of money that is y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products borrowed without including any interest or additional fee’s. Term Term refers to the length of a debt a . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de reement. For example if you were to take out a loan for a house over 10 years. 10 years would be the term. Feel fre elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip e to reprint this article as long as you keep the following caption and author biography in tact with all hyperlinks tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Why You Should Agree With Royalty Fees How to Plan Fund Raising Events Ecommerce Web Site Template -- Know Your Content, Find a Template That Fits
|